Khaled Aldahmani is a Consultant Endocrinologist at Tawam Hospital in Al Ain. United Arab Emirates. He is also a Visiting Endocrinologist at New Medical Center (NMC) and Adjunct Faculty of the Department of Medicine at United Arab Emirates University. Dr. Aldahmani obtained his MBBS at the UAE University in 2006 and completed his residency in Internal Medicine at the University of British Columbia in 2011 and fellowship in Endocrinology at the Dalhousie University. Canada in 2013. Then he completed 1 year training in Pituitary Disorders and Thyroid cancer at Dalhousie University in 2014. He received board certification in Endocrinology. Diabetes and Metabolism (2013) and Internal Medicine (2011) from the American Board of Internal Medicine. as well as a certificate in Endocrinology and Metabolism (2013) and Internal Medicine (2011) from the Fellow of Royal College of Physicians and Surgeons Canada. He is a founding member and the chairman of AlAin Internal Medicine Research conference since 2015.
Dr. Aldahmani has special interest in pituitary disorders and has published the largest population based epidemiological study on sellar masses in North America. He is also a co-author of several other publications.